2/26/2021Financial-related Company News in Brief

2/26/2021Recent Executive Moves

2/26/2021NMPA Announces Package Insert Revision of Misoprostol Tablets

2/26/2021CANbridge Pharma and Puma Biotech Agree to Terminate NERLYNX License...

2/25/2021CDE Issues the Technical Guidelines for Non-clinical Studies of Radioa...

2/25/2021CDE Seeks Comments on Implementation Advice on ICH Guidelines Q5D, M9 ...

2/25/2021AstraZeneca Gains Default Chinese IND Approval for Its Class 1 New Bio...

2/25/2021Snapshot of BMI System Financial Performance in 2020

2/25/2021China Approves Two More Domestic COVID-19 Vaccines

2/25/2021Puma Biotech and Pierre Fabre Amend NERLYNX License Deal to Include G...

2/25/2021Harbour BioMed Announces Chinese IND Approval of for Combo Therapy of ...

2/25/2021PharmaNJ's China NMPA Approved Tracker: Jan 2021

2/25/2021Biosecurity Law of the P.R.C. - Full Text Unofficial Translation

2/24/2021Review of Chinese Import Chemical Drug IND Applications in 2020

2/24/2021Snapshot of MNC Products in the 2020 NRDL

2/24/2021Kuehne+Nagel Forms Strategic Partnership with Chinese Pharma Specialis...

2/24/2021Gannex Receives U.S. IND Approval for THR-β Agonist ASC41 for NASH

2/23/2021NMPA Issues the List of Reference Formulations for GQCE Studies (38th ...

2/23/2021CDE Issues New Guideline Document for Publication of Technical Evaluat...

2/23/2021NMPA Solicits Comments on the Draft Technical Guidelines for Non-clini...

2/23/2021Indian Pharma Firms Go Local Seeking to End Reliance on China

2/23/2021Solentim Expands Gglobal Rreach, Opening New Operation in China

2/23/2021Graviton Enters into Global Licensing Agreement for ROCK2 Inhibitor fr...

2/23/2021Review of Chinese Pharma Deals, R&D and Regulatory Developments in 202...

2/23/2021PharmaDJ's China Licensing Deals Tracker: Jan 2021

2/22/2021How Foreign Companies Can Break Into China's Biosimilar Market and Rel...

2/22/2021The Race to the Top: Does China Have What It Takes?

2/22/2021IHS Markit: China Pharma in the Year of the Ox

2/22/2021Anticancer Medicines in China: Trends in Daily Therapy Cost and Relati...

2/22/2021Junshi Bio Wins Chinese Conditional Approval for 2nd Indication for T...

Page:213/790 Total number of articles:23677: [First][<<] [211] [212] [213] [214] [215] [>>] [End]